FGC
MYGN icon

Financial Gravity Companies’s Myriad Genetics MYGN Stock Holding History

Financial Gravity Companies’s Portfolio MYGN Stock Details MYGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		$42K Buy
+1,544
New +$55.5K 0.04% 385
2018
Q1 		$5K Buy
172
+17
+11% +$575 0.01% 737
2017
Q4 		$6K Buy
+155
New +$5.23K 0.01% 676

Other funds holding MYGN

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
FCM
Frontier Capital Management Boston, Massachusetts $9.73B AUM 55.65% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
CCM
Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Financial Gravity Companies's MYGN Position: Q4 2018 in Review

Financial Gravity Companies opened a new position in Myriad Genetics (MYGN) in Q4 2018: 1,544 shares worth $42K. The stake represents 0.04% of the portfolio and ranks #385 among its holdings. This is a return to the name: Financial Gravity Companies previously reported a position in MYGN as recently as Q1 2018.

Financial Gravity Companies first reported a position in MYGN in Q4 2017 and has held it in 3 quarters since. 264 funds tracked by Wall St. Rank hold MYGN as of Q4 2018.

  • Financial Gravity Companies held 1,544 shares of Myriad Genetics worth $42K as of Q4 2018.
  • Myriad Genetics was a new Financial Gravity Companies position in Q4 2018.
  • Myriad Genetics made up 0.04% of Financial Gravity Companies's portfolio in Q4 2018, its #385 holding.
  • Financial Gravity Companies first reported a position in Myriad Genetics in Q4 2017 and has held it in 3 quarters since.
  • 264 funds tracked by Wall St. Rank held Myriad Genetics as of Q4 2018.

Based on Financial Gravity Companies's 13F filing for Q4 2018, filed 4 Feb 2019.